Paper Details

  1. Home
  2. Paper Details

[Why do good drugs disappear?].

Author: BrezisMayer, HammermanAriel, KlangSamuel, TomerRon

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This article discusses the disappearance of old drugs from the market due to market failures and failures in production and regulatory processes. Switching to newer agents increases costs and is often associated with relative uncertainty about safety and efficacy. System revisions are needed to allow continued availability of old, safe and effective drugs.
Paper Details　
Original Abstract of the Article :
Old drugs, with proved efficacy and safety, are disappearing from the market. For instance, nitrofurantoin, an inexpensive effective agent for urinary tract infections with low incidence of bacterial resistance in comparison to other antibiotics, is becoming unavailable. Alpha-methyldopa and hydraLa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/21568061

データ提供：米国国立医学図書館（NLM）

The Disappearance of Good Drugs: A Crisis in the Pharmaceutical Industry

This study examines the concerning trend of effective and safe medications being withdrawn from the market. The authors highlight the case of several valuable drugs, such as nitrofurantoin for urinary tract infections and alpha-methyldopa for pregnancy hypertension, that have become unavailable due to complex factors related to market forces, production challenges, and regulatory processes.

Navigating the Desert of Pharmaceutical Development

The study's findings raise concerns about the sustainability of healthcare systems, as the disappearance of effective drugs can lead to increased costs, limited patient choices, and potential compromises in treatment outcomes. It's like navigating a desert landscape where once-reliable oases have vanished, leaving travelers to search for alternative sources of sustenance and support.

The Future of Medicine: Finding New Oasis in the Desert

The pharmaceutical industry faces a critical challenge in ensuring the continued availability of safe and effective medications. This study calls for systemic revisions to address market failures and streamline regulatory processes to protect access to essential drugs. It's like exploring a vast and unforgiving desert—we must work together to create new oases and secure a sustainable future for healthcare.

Dr.Camel's Conclusion

This study raises important questions about the dynamics of the pharmaceutical industry and the need to prioritize patient access to essential medications. It underscores the importance of finding solutions that address market failures, production challenges, and regulatory complexities to ensure the continued availability of effective drugs.
Date :
  1. Date Completed 2011-06-07
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21568061

DOI: Digital Object Identifier

21568061

SNS
PICO Info
in preparation
Languages

Hebrew

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.